cytokinetics - Robuta Search

https://www.healthcaretimesutah.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Healthcare Times Utah public offering common stock cytokinetics announces proposed https://finviz.com/news/345889/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Stock screener for investors and traders, financial visualizations. cytokinetics announces grants https://www.yemenhealthreport.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Yemen Health Report public offering common stock cytokinetics announces proposed https://tennesseehealthcaretoday.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Tennessee... first quarter financial results https://crueltyfreeinvesting.org/companies/cytokinetics-incorporated/ Cytokinetics, Incorporated - Cruelty Free Investing Oct 17, 2025 - Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for... cruelty free cytokinetics incorporated investing https://surinamehealthcarepress.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Suriname Healthcare Press public offering common stock cytokinetics announces proposed https://cedar-hcm.com/ Homepage - Cytokinetics Cedar Trial Site Apr 7, 2026 - Cytokinetics Cedar Trial Site homepage cytokinetics cedar trial site https://ir.cytokinetics.com/overview/default.aspx Cytokinetics, Incorporated - Investor Relations cytokinetics incorporated investor relations https://www.michiganbusinesstribune.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Michigan Business... public offering common stock cytokinetics announces pricing https://middleeastpoliticalobserver.com/article/863975952-cytokinetics-incorporated-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-november-17-2025-to-discuss-your-rights Cytokinetics, Incorporated Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky... class action lawsuit securities fraud cytokinetics incorporated https://cytokinetics.com/medicines-research/pipeline/publications/page/77/ Publications | Medicines & Research | Cytokinetics May 9, 2025 - Cytokinetics is a leader in muscle biology research. View the science behind Cytokinetics and read our publications today. publications medicines research cytokinetics https://politicstodaymauritania.com/article/855024600-portnoy-law-firm-announces-class-action-on-behalf-of-cytokinetics-inc-investors Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Inc. Investors | Politics Today... https://kentuckyhealthwire.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Kentucky... first quarter financial results https://healthcaredigestofvermont.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Healthcare... first quarter financial results https://50statestoday.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | 50 States Today 50 States Today is an online news publication focusing on the United States: The top news stories from the United States public offering https://healthwireburundi.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Health... first quarter financial results https://healthcareexaminerturkscaicos.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Healthcare Examiner Turks & Caicos public offering https://healthdailysouthcarolina.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Health Daily of South Carolina public offering https://www.healthwireeasttimor.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Health Wire East Timor https://www.samoawellnessreport.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Samoa Wellness Report public offering common stock cytokinetics announces proposed https://cytokinetics.com/company/senior-management/team-member/jeff-lotz/ Jeff Lotz | VP, Sales and Operations | Cytokinetics Jul 28, 2025 - Jeff joined Cytokinetics as Vice President, Sales and Operations in September 2021. Jeff has an extensive biopharma background of over 25 years. sales and operations jeff vp cytokinetics https://247businessreporter.com/article/855285397-bragar-eagel-squire-p-c-reminds-investors-of-vfc-cytokinetics-quanex-and-rci-to-contact-the-firm-about-their-rights-in-filed-class-action Bragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI to Contact the... https://solomonislandshealthreporter.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Solomon... first quarter financial results https://healthwirecaboverde.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Health... first quarter financial results https://stemtimescaymanislands.com/article/813756463-cytokinetics-presents-additional-data-related-to-aficamten-at-the-european-society-of-cardiology-heart-failure-2025-congress Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology... https://healthreportequatorialguinea.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Health Report... public offering common stock cytokinetics announces pricing https://automotivepressreleases.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Automotive Press... Automotive Press Releases is an online news publication focusing on industries in the World: Following automotive industry news from the world public offering common stock cytokinetics announces pricing https://www.andorrahealthwatch.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Andorra Health Watch public offering common stock cytokinetics announces proposed https://healthcaretodaybahrain.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Healthcare Today Bahrain public offering common stock healthcare today cytokinetics announces https://www.pienomial.com/clinical-trial-intelligen/cytokinetics-heart-drug-scores-in-closely-watched-trial Cytokinetics Myqorzo Phase 3 Success in Non-Obstructive HCM | Pienomai Cytokinetics' Myqorzo achieved positive Phase 3 results for non-obstructive hypertrophic cardiomyopathy, meeting dual primary endpoints with significant... cytokinetics phase success non hcm https://www.businessdailywesternsahara.com/article/864307883-cytokinetics-to-participate-in-november-investor-conferences Cytokinetics to Participate in November Investor Conferences | Business Daily Western Sahara investor conferences business daily cytokinetics participate november https://www.healthcaretodaymichigan.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Healthcare Today Michigan public offering common stock healthcare today cytokinetics announces https://www.fool.com/quote/nasdaq/cytk/ Cytokinetics - CYTK - Stock Price & News | The Motley Fool stock price cytokinetics cytk news motley https://lifesciencetracker.com/companies/cytokinetics-inc/ Cytokinetics Inc Archives - Incubate Investment Tracker cytokinetics inc archives investment tracker https://www.stkittsnevisbusinesswatch.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | St. Kitts & Nevis... public offering https://www.yemenhealthreport.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Yemen... first quarter financial results https://www.amgen.com/newsroom/press-releases/2020/10/amgen-cytokinetics-and-servier-announce-topline-results-from-galactichf-a-phase-3-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of... https://www.vaticanhealthtimes.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Vatican... first quarter financial results https://www.healthcaretimesguadeloupe.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Healthcare... first quarter financial results https://rhodeislandbusinessdaily.com/article/855024600-portnoy-law-firm-announces-class-action-on-behalf-of-cytokinetics-inc-investors Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Inc. Investors | Rhode Island... https://illinoiswellnessinsider.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | The Illinois Wellness... public offering https://healthdailyamericansamoa.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Health Daily American Samoa public offering https://www.wisconsinhealthpress.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Wisconsin Health Press public offering https://www.politicalrecordmalta.com/article/864415708-cytokinetics-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-investors-with-losses-in-excess-of-100-000-of Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds... https://www.healthwireburundi.com/article/910599295-cytokinetics-reports-first-quarter-2026-financial-results-and-provides-business-update Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update | Health... first quarter financial results https://cytokinetics.com/medicines-research/ Medicines and Research | Cytokinetics medicines research cytokinetics https://www.topekapoliticaljournal.com/article/820745812-cytokinetics-announces-call-for-proposals-for-annual-corporate-giving-program Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program | Topeka Political... call for proposals corporate giving program cytokinetics announces https://latinamericahealthtimes.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Latin America Health... public offering https://thealbanypost.com/article/854982940-cytk-investor-alert-bronstein-gewirtz-grossman-llc-announces-that-cytokinetics-incorporated-investors-with-substantial-losses-have-opportunity-to CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated... The Albany Post is an online news publication focusing on the New York: Your daily news update on New York investor alert cytk https://healthcarenewspapuanewguinea.com/article/910600002-cytokinetics-announces-proposed-public-offering-of-common-stock Cytokinetics Announces Proposed Public Offering of Common Stock | Healthcare News Papua New Guinea https://www.georgianbusinesstimes.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock | Georgian Business Times public offering https://www.moronipoliticalobserver.com/article/854465430-cytokinetics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuits CYTOKINETICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of... https://www.bioworld.com/articles/694707-fda-cites-weak-efficacy-as-it-hands-cytokinetics-crl-for-heart-failure-drug FDA cites weak efficacy as it hands Cytokinetics CRL for heart failure drug | BioWorld Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,... https://www.healthchanneltogo.com/article/864307883-cytokinetics-to-participate-in-november-investor-conferences Cytokinetics to Participate in November Investor Conferences | Health Channel of Togo investor conferences health channel cytokinetics participate november